Buprenorphine in Pregnancy and Conflicting Advice
Aisha, 31, is 14 weeks pregnant and has been stable on buprenorphine/naloxone 16 mg daily for two years, with negative urine screens for 18 months. She is housed, employed, and engaged in prenatal care. Her obstetrician has asked your program to "help her get off the buprenorphine to protect the baby." Aisha has read online that her baby will be "born addicted" and wants to taper to zero by her third trimester. She is frightened and asking you to help her decide. You are her counselor; the buprenorphine is prescribed by a different physician.
1. How do you respond to the obstetrician's request and to Aisha's goal?
Read the worked answer
Neither the OB's request nor Aisha's preference should be acted on as stated - but neither gets dismissed.
What the evidence supports: Medication for opioid use disorder with buprenorphine or methadone is the standard of care in pregnancy. Abrupt or rapid tapering risks maternal withdrawal, which is associated with preterm labor, fetal distress, and - most importantly - relapse to illicit opioid use. Relapse carries the highest risk of all: overdose, infection, loss of prenatal care, and fetal death. Stability on medication is the protective factor Aisha currently has.
On "born addicted": what is being described is neonatal opioid withdrawal syndrome, which is expected, treatable, and managed by the pediatric team with supportive care and, when needed, medication. It is not a permanent injury, and it does not mean the infant is "addicted." She should hear the difference between physical dependence and addiction - a distinction that matters for her self-image and for her decision.
On the OB: the request reflects a common but outdated fear. Your approach is not to override a physician, but to say to Aisha, "You have two professionals telling you different things. That's worth resolving before you change anything," and to facilitate a three-way conversation with the prescriber and the OB.
Do not taper advice yourself. That is the prescriber's call.
2. What is your role versus the prescriber's, and what specific actions do you take in the next two weeks?
Read the worked answer
Scope You do not adjust dose, choose formulations, or design a taper. You provide education, decision support, coordination, and documentation. The buprenorphine prescriber owns the medication decision; the OB owns prenatal care; a consultation with addiction medicine or a high-risk obstetrics clinic resolves disagreements.
Actions
- Get a Part 2-compliant written consent to communicate with both the prescriber and the OB.
- Contact the prescriber first, before any conversation about dose change, and report what Aisha has been told and what she is requesting.
- Request a joint conversation (in person or by phone) with Aisha, the prescriber, and the OB. Conflicting advice delivered separately is what is frightening her.
- Offer accurate written material on medication for opioid use disorder in pregnancy and on neonatal opioid withdrawal syndrome, and check her understanding rather than assuming it.
- Ask the prescriber whether a switch to the monoproduct is appropriate - that is a prescriber decision, but it is a reasonable question to route to them.
- Screen for relapse risk factors - housing, supports, prenatal appointment attendance - and reinforce them.
Document the education given, the referrals, and the coordination attempts, including any that go unanswered.
3. Aisha insists on tapering anyway. What do you do?
Read the worked answer
Support her agency while ensuring the decision is informed, supervised, and reversible.
Before anything changes
- Confirm she has actually heard the risks in specific terms: preterm labor, fetal distress, return to illicit use, overdose risk, and the possibility that a taper is followed by relapse at a dose she no longer tolerates.
- Ask what specifically is driving the decision - fear of judgment at the hospital, fear of child protective services, something she read. Those fears are often addressable, and a plan built around them may change her mind more than another recitation of risk.
If she still proceeds
- Insist the taper be prescriber-directed, never self-managed. A self-directed taper is the dangerous version.
- Make sure the OB knows, so prenatal monitoring intensifies.
- Increase contact frequency during and after the taper; adjust the level of care if relapse risk rises.
- Have an explicit re-escalation plan in writing: if she uses, she calls the prescriber and restarts medication rather than hiding it. Shame is the main reason people disappear after a lapse.
- Do not discharge her for disagreeing with you. Discharge is the intervention most likely to produce harm.
Document the education provided, the risks discussed, her stated reasons, the prescriber's involvement, and the safety plan. Note that you recommended continuing medication - an honest record protects both of you and, more importantly, keeps the clinical picture visible to the next provider.
If you believe the OB is pressuring her toward an unsafe taper, escalate to your supervisor and advocate - that is within your role.